GAMA
EDIT icon

Graticule Asia Macro Advisors’s Editas Medicine EDIT Stock Holding History

Graticule Asia Macro Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$1.12M – 126
2017
Q1 		$1.12M Buy
+50,000
New +$1.04M 0.07% 105

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Graticule Asia Macro Advisors's EDIT Position: Q2 2017 in Review

Graticule Asia Macro Advisors sold out of Editas Medicine (EDIT) in Q2 2017, closing a stake of 50,000 shares — an estimated $1.12M sold.

Graticule Asia Macro Advisors first reported a position in EDIT in Q1 2017 and held it in 1 quarter. The position peaked at $1.12M in Q1 2017. 110 funds tracked by Wall St. Rank hold EDIT as of Q2 2017.

  • Graticule Asia Macro Advisors reported no remaining Editas Medicine position as of Q2 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 50,000 Editas Medicine shares in Q2 2017, an estimated $1.12M.
  • Graticule Asia Macro Advisors first reported a position in Editas Medicine in Q1 2017 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Editas Medicine position peaked at $1.12M in Q1 2017.
  • 110 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.